The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

Caroline Rush will officially step down from her role as chief executive officer of the British Fashion Council (BFC), ...

With inflation subsiding, the European Central Bank cut interest rates again on Thursday to prop up tepid growth with lower ...

Previous studies have consistently reported a decrease in hospital admissions for respiratory diseases during the coronavirus disease 2019 (COVID-19) pandemic. However, the impact of the pandemic on ...

Presentations made by Pliant colleagues and investigators at the 2024 ERS Congress include additional clinical data from our recently announced type 1 collagen PET imaging study, an integrated safety ...

Ivaltinostat is under clinical development by CG Invites and currently in Phase I for Alport Syndrome. According to GlobalData, Phase I drugs for Alport Syndrome have an 88% phase transition success ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 16 on August 29, 2024, entitled, “Leukocyte telomere ...

We hypothesized that CF patients with more severe disease characteristics exhibit shorter leukocyte telomere length (LTL) and greater LTL ...

A risk score designed to guide vaccine decisions showed good accuracy in predicting LRTI complications leading to hospitalization or death.

Low dose morphine has the potential to treat chronic cough in people with idiopathic pulmonary fibrosis (IPF), according to new research from two National Institute for Health and Care ...